D&C Rules need revamp as there is no clause of compensation for ADRs: regulatory experts
AuroBlog - Aurous Healthcare Clinical Trials blog
JANUARY 19, 2023
Taking into account the four main components of regulator, industry, trade and patient/consumer in a medicine value supply chain, the Drugs and Cosmetics (D&C) Rules, 1945 and D&C Act, 1940 needs an urgent revamp as there is no clause of compensation for ADRs in patients, according to drug regulatory experts.
Let's personalize your content